Engineering of CAR-T cells that overcome MYC-dependent immunosuppression in a genetically engineered mouse model of pancreatic cancer (B05)

• Subject Area: Hematology, Oncology ; Gastroenterology
• Term: since 2021
• Project identifier: Deutsche Forschungsgemeinschaft (DFG) - Project number 452881907

No abstract available

• DFG Programme: CRC/Transregios
• Subproject of: TRR 338: LETSIMMUN - Lymphocyte Engineering for Therapeutic Synthetic Immunity
• Applicant Institution: Technische Universität München (TUM)
• Project Heads: Eva Bräunlein, Ph.D., since 1/2026; Dr. Sophia Danhof; Professor Dr. Martin Eilers, until 12/2025